EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The lysosomal acid lipase deficiency spectrum from infancy to adulthood: a multidisciplinary experience

Raffaele Buganza, Riccardo Faletti, Maria Donata Di Taranto, Angelo Armandi, Giulia Massini, Luisa de Sanctis, Ornella Guardamagna

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2025.104277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Raffaele Buganza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Pediatric Sciences, Ospedale Infantile Regina Margherita, University of Turin, Italy. Hauptthemen laut MEDLINE: Wolman Disease, Sterol Esterase, Cholesterol Ester Storage Disease, Enzyme Replacement Therapy. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Lysosomal acid lipase (LAL) deficiency, an ultrarare autosomal recessive disorder related to LIPA gene variants, presents two clinical phenotypes: Wolman's disease (WD), which occurs early with severe presentation, and Cholesteryl Ester Storage Disease (CESD) with a milder and variable course mainly affecting lipid metabolism and liver function. Misdiagnosis risk, treatment effectiveness and long-term outcome are significant issues. Enzyme replacement therapy (ERT) represents the only effective choice in WD. This study aims to address diagnostic and therapeutic challenges and to explore the long-term effects of lipid-lowering therapy (LLT) in CESD. METHODS AND RESULTS: We retrospectively analyzed data collected over the last 30 years from seven LAL deficiency (LAL-D) patients, 2 WD infants and 5 CESD children and adults, including biochemical analysis, LAL enzyme activity, LIPA gene variants, carotid intima-media thickness and liver assessments by ultrasound, magnetic resonance imaging, transient elastography and biopsy. The variability of first clinical presentation delayed the diagnosis of CESD (from 4 to 52 years). WD twin infants presented with severe liver and gastrointestinal symptoms and died before 9 months of age. Ezetimibe treatment led to LDL-C and ALT improvement in 4/5 CESD patients (LDL-C 19 %, ALT 21.6 % mean decreases) without progression of liver fibrosis in the mid-to long-term follow-up. CONCLUSION: LAL-D mimics hyperlipidemias and liver disorders making a definitive diagnosis mandatory. Patients with CESD presentation should benefit from first level treatment with LLT before considering ERT which represents the option in case of unresponsiveness or symptoms progression while it represents the elective therapy for WD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wolman DiseaseSterol EsteraseCholesterol Ester Storage DiseaseEnzyme Replacement TherapyHypolipidemic AgentsHumansRetrospective StudiesMaleFemaleChild, PreschoolChildAdultAdolescentPhenotypeInfantYoung AdultTreatment OutcomeMiddle AgedBiomarkersTime FactorsAge FactorsGenetic Predisposition to DiseasePredictive Value of Tests

Stichwörter der Autor:innen

CESDCESD treatmentLAL-D follow-upLysosomal acid lipase deficiencyWolman

Substanzen

Sterol EsteraseLIPA protein, humanBiomarkersHypolipidemic Agents

Autor:innen und Institutionen

  • Department of Public Health and Pediatric Sciences, Ospedale Infantile Regina Margherita, University of Turin, Italy.
  • Department of Surgical Sciences, Radiology Unit, University of Turin, Italy.
  • Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, CEINGE Biotecnologie Avanzate s.c. a r.l., Naples, Italy.
  • Division of Gastroenterology and Hepatology, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Department of Public Health and Pediatric Sciences, Ospedale Infantile Regina Margherita, University of Turin, Italy. Electronic address: ornella.guardamagna@unito.it.

Zitieren

APA

Buganza, R., Faletti, R., Di Taranto, M. D., Armandi, A., Massini, G., de Sanctis, L., & Guardamagna, O. (2025). The lysosomal acid lipase deficiency spectrum from infancy to adulthood: a multidisciplinary experience. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104277

Vancouver

Buganza R, Faletti R, Di Taranto MD, Armandi A, Massini G, de Sanctis L, et al. The lysosomal acid lipase deficiency spectrum from infancy to adulthood: a multidisciplinary experience. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104277

BibTeX
@article{Buganza2025,
  author = {Buganza, Raffaele and Faletti, Riccardo and Di Taranto, Maria Donata and Armandi, Angelo and Massini, Giulia and de Sanctis, Luisa and Guardamagna, Ornella},
  title = {The lysosomal acid lipase deficiency spectrum from infancy to adulthood: a multidisciplinary experience},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2025.104277}
}
Kostenlos starten →